Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Immunotherapy in malignant melanomaa

E C Homes, D L Morton, F R Eilber

National Cancer Institute Monograph

|November 1, 1976

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The use of sentinel lymphadenectomy to identify candidates for postoperative adjuvant therapy of melanoma and breast cancer.

Seminars in oncology·2001

Same author

Cytoreductive surgery and adjuvant immunotherapy: a new management paradigm for metastatic melanoma.

CA: a cancer journal for clinicians·2001

Same author

Immunology of gangliosides.

Indian journal of experimental biology·2001

Same author

Molecular staging of early colon cancer on the basis of sentinel node analysis: a multicenter phase II trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2001

Same author

Tumor-associated antigen TA90 immune complex assay predicts recurrence and survival after surgical treatment of stage I-III melanoma.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2001

Same author

The clinical utility of multimarker RT-PCR in the detection of occult metastasis in patients with melanoma.

Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer·2000

This study investigates immunotherapy for melanoma patients. Postoperative Bacillus Calmette-Guérin (BCG) immunotherapy, alone or with vaccine, may improve survival and reduce recurrence in Stage II melanoma.

Area of Science:

Oncology
Immunology
Cancer Research

Background:

Human neoplasms possess antigens that trigger immune responses.
Previous studies indicated improved survival and reduced recurrence in Stage II melanoma patients receiving surgery and Bacillus Calmette-Guérin (BCG) immunotherapy.

Purpose of the Study:

To verify findings on the efficacy of BCG immunotherapy in melanoma patients.
To compare surgery alone versus surgery with BCG immunotherapy, or surgery with BCG and allogeneic melanoma cell vaccine.

Main Methods:

Randomized clinical trials involving melanoma patients.
Monitoring of patient serum samples using in vitro techniques.
Correlation of in vitro findings with clinical outcomes.

Related Experiment Videos

Main Results:

Ongoing clinical trials are evaluating treatment efficacy.
In vitro monitoring aims to identify methods correlating with clinical course.
Immunotherapy is expected to be beneficial against subclinical tumors.

Conclusions:

Immunotherapy shows promise for managing microscopic melanoma.
Further research is needed to optimize immunotherapy strategies.
Correlations between in vitro markers and clinical outcomes could enable early response monitoring.